Literature DB >> 22548573

Energy metabolism plasticity enables stemness programs.

Clifford D L Folmes1, Timothy J Nelson1, Petras P Dzeja1, Andre Terzic1.   

Abstract

Engineering pluripotency through nuclear reprogramming and directing stem cells into defined lineages underscores cell fate plasticity. Acquisition of and departure from stemness are governed by genetic and epigenetic controllers, with modulation of energy metabolism and associated signaling increasingly implicated in cell identity determination. Transition from oxidative metabolism, typical of somatic tissues, into glycolysis is a prerequisite to fuel-proficient reprogramming, directing a differentiated cytotype back to the pluripotent state. The glycolytic metabotype supports the anabolic and catabolic requirements of pluripotent cell homeostasis. Conversely, redirection of pluripotency into defined lineages requires mitochondrial biogenesis and maturation of efficient oxidative energy generation and distribution networks to match demands. The vital function of bioenergetics in regulating stemness and lineage specification implicates a broader role for metabolic reprogramming in cell fate decisions and determinations of tissue regenerative potential.
© 2012 New York Academy of Sciences.

Entities:  

Mesh:

Year:  2012        PMID: 22548573      PMCID: PMC3495059          DOI: 10.1111/j.1749-6632.2012.06487.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   6.499


  99 in total

1.  Cardiovascular health: the global challenge.

Authors:  S A Waldman; A Terzic
Journal:  Clin Pharmacol Ther       Date:  2011-10       Impact factor: 6.875

Review 2.  Guidelines and techniques for the generation of induced pluripotent stem cells.

Authors:  Nimet Maherali; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2008-12-04       Impact factor: 24.633

3.  Chronic diseases: the emerging pandemic.

Authors:  Andre Terzic; Scott Waldman
Journal:  Clin Transl Sci       Date:  2011-06       Impact factor: 4.689

Review 4.  The stuttering progress of cell therapy for heart disease.

Authors:  K Malliaras; M Kreke; E Marbán
Journal:  Clin Pharmacol Ther       Date:  2011-09-07       Impact factor: 6.875

5.  Derivation of a cardiopoietic population from human mesenchymal stem cells yields cardiac progeny.

Authors:  Atta Behfar; Andre Terzic
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2006-03

6.  Mitochondrial rejuvenation after induced pluripotency.

Authors:  Steven T Suhr; Eun Ah Chang; Jonathan Tjong; Nathan Alcasid; Guy A Perkins; Marcelo D Goissis; Mark H Ellisman; Gloria I Perez; Jose B Cibelli
Journal:  PLoS One       Date:  2010-11-23       Impact factor: 3.240

7.  Enhancement of human embryonic stem cell pluripotency through inhibition of the mitochondrial respiratory chain.

Authors:  S Varum; O Momcilović; C Castro; A Ben-Yehudah; J Ramalho-Santos; C S Navara
Journal:  Stem Cell Res       Date:  2009-08-03       Impact factor: 2.020

8.  Generation of germline-competent induced pluripotent stem cells.

Authors:  Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

Review 9.  Guided stem cell cardiopoiesis: discovery and translation.

Authors:  Atta Behfar; Randolph S Faustino; D Kent Arrell; Petras P Dzeja; Carmen Perez-Terzic; Andre Terzic
Journal:  J Mol Cell Cardiol       Date:  2008-09-26       Impact factor: 5.000

10.  Dependence of mouse embryonic stem cells on threonine catabolism.

Authors:  Jian Wang; Peter Alexander; Leeju Wu; Robert Hammer; Ondine Cleaver; Steven L McKnight
Journal:  Science       Date:  2009-07-09       Impact factor: 47.728

View more
  40 in total

1.  Inhibition of an NAD⁺ salvage pathway provides efficient and selective toxicity to human pluripotent stem cells.

Authors:  Erin M Kropp; Bryndon J Oleson; Katarzyna A Broniowska; Subarna Bhattacharya; Alexandra C Chadwick; Anne R Diers; Qinghui Hu; Daisy Sahoo; Neil Hogg; Kenneth R Boheler; John A Corbett; Rebekah L Gundry
Journal:  Stem Cells Transl Med       Date:  2015-04-01       Impact factor: 6.940

2.  Metabolome and metaboproteome remodeling in nuclear reprogramming.

Authors:  Clifford Dl Folmes; D Kent Arrell; Jelena Zlatkovic-Lindor; Almudena Martinez-Fernandez; Carmen Perez-Terzic; Timothy J Nelson; Andre Terzic
Journal:  Cell Cycle       Date:  2013-07-08       Impact factor: 4.534

Review 3.  Pluripotent stem cell energy metabolism: an update.

Authors:  Tara Teslaa; Michael A Teitell
Journal:  EMBO J       Date:  2014-12-04       Impact factor: 11.598

Review 4.  Metabolic restructuring and cell fate conversion.

Authors:  Alessandro Prigione; María Victoria Ruiz-Pérez; Raul Bukowiecki; James Adjaye
Journal:  Cell Mol Life Sci       Date:  2015-01-14       Impact factor: 9.261

5.  Resistance of glia-like central and peripheral neural stem cells to genetically induced mitochondrial dysfunction--differential effects on neurogenesis.

Authors:  Blanca Díaz-Castro; Ricardo Pardal; Paula García-Flores; Verónica Sobrino; Rocío Durán; José I Piruat; José López-Barneo
Journal:  EMBO Rep       Date:  2015-09-21       Impact factor: 8.807

Review 6.  The role of mitochondria in stem cell fate and aging.

Authors:  Hongbo Zhang; Keir J Menzies; Johan Auwerx
Journal:  Development       Date:  2018-04-13       Impact factor: 6.868

7.  Nonlinear regression models for determination of nicotinamide adenine dinucleotide content in human embryonic stem cells.

Authors:  Anton Salykin; Petr Kuzmic; Olga Kyrylenko; Jindra Musilova; Zdenek Glatz; Petr Dvorak; Sergiy Kyrylenko
Journal:  Stem Cell Rev Rep       Date:  2013-12       Impact factor: 5.739

8.  Nuclear reprogramming with c-Myc potentiates glycolytic capacity of derived induced pluripotent stem cells.

Authors:  Clifford D L Folmes; Almudena Martinez-Fernandez; Randolph S Faustino; Satsuki Yamada; Carmen Perez-Terzic; Timothy J Nelson; Andre Terzic
Journal:  J Cardiovasc Transl Res       Date:  2012-12-18       Impact factor: 4.132

Review 9.  The mitochondrial H(+)-ATP synthase and the lipogenic switch: new core components of metabolic reprogramming in induced pluripotent stem (iPS) cells.

Authors:  Alejandro Vazquez-Martin; Bruna Corominas-Faja; Sílvia Cufi; Luciano Vellon; Cristina Oliveras-Ferraros; Octavio J Menendez; Jorge Joven; Ruth Lupu; Javier A Menendez
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

10.  Glycolytic Metabolism Plays a Functional Role in Regulating Human Pluripotent Stem Cell State.

Authors:  Wen Gu; Xavier Gaeta; Anna Sahakyan; Alanna B Chan; Candice S Hong; Rachel Kim; Daniel Braas; Kathrin Plath; William E Lowry; Heather R Christofk
Journal:  Cell Stem Cell       Date:  2016-09-08       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.